EQUITY RESEARCH MEMO

West Coast Research

Generated 5/11/2026

Executive Summary

Conviction (model self-assessment)55/100

West Coast Research LLC is a privately-held clinical research organization (CRO) based in Dublin, California, specializing in patient-centered clinical trials for pharmaceutical and medical technology sponsors. Founded in 2007, the company operates a single-site clinic focused primarily on diagnostics and therapeutics, with recent emphasis on conditions such as gout and hypertension. Despite operating from a single location, West Coast Research has carved a niche in site management, offering efficient patient enrollment and trial execution for small-to-mid-sized studies. The company's lean structure allows it to adapt quickly to sponsor needs, though its limited geographic footprint may constrain scalability. Given the growing demand for decentralized and site-managed trials, West Coast Research is well-positioned to capture additional business, though competition from larger CROs remains a challenge. The company's private status means detailed financial performance is unavailable, but its sustained operation since 2007 suggests a stable revenue base from recurring clinical trial contracts.

Upcoming Catalysts (preview)

  • Q4 2026Expansion of clinical trial capacity through new partnerships60% success
  • Q2 2027Completion of a high-profile gout or hypertension study70% success
  • TBDPotential acquisition by a larger CRO seeking site network30% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)